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Impact of Percutaneous Coronary Intervention on Twelve-month Chronic Total
Occlusion Outcomes in Patients with Smoking History
Yoonjee Park, Seung-Woon Rha, Byoung Geol Choi, Se Yeon Choi, Cheol Ung Choi,
Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo,
Dong Joo Oh
Korea University Guro Hospital, Seoul, Korea (Republic of)
Background: The impact of percutaneous coronary intervention (PCI) for chronic
total occlusion (CTO) in patients with smoking history is not clear. Smoking history is
known to have an adverse effect on clinical outcomes of coronary artery diseases. We
evaluated the 12-month clinical outcomes between PCI and optimal medical therapy
(OMT) for CTO lesions in patients with smoking history.
Methods: A total of 321 consecutive CTO patients with smoking history were divided
into 2 groups according to treatment strategy; PCI group (n¼145) and OMT group
(n¼176). Twelve–month clinical outcomes were retrospectively compared between
the two groups.
Results: At baseline, patients in the OMT group had a lower left ventricular ejection
fraction, and higher prevalence of elderly, cerebrovascular accident, peripheral
vascular disease, congestive heart failure, left main disease, multivessel disease, right
coronary artery CTO lesion, and collaterals grade 2. Clinical outcomes at 12 months
were similar between the 2 groups except lower mortality in the PCI group at uni-
variate analysis. After baseline adjustment by multivariate analysis, 12-month mor-
tality remained lower in the PCI group (OR 0.112, 95% CI 0.014-0.910, p¼0.041)
despite of increased target lesion revascularization (TLR) in the PCI group (table).
Conclusion: In our study, PCI seems to be a favorable choice of therapy for CTO
lesions in patients with smoking history in terms of reducing 12-month mortality.
Long-term follow up with a larger study population will be necessary for further
clariﬁcation.TCTAP A-176
Comparison of 3-year Clinical Outcomes According to the Response to
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Background: There have been many studies regarding acetylcholine (Ach) induced
coronary artery spasm (CAS). However, although spastic coronary artery at baseline
coronary angiography is common in clinical practice, clinical outcomes according to
the response to Ach in patients with basal CAS are unknown.
Methods: A total of 728 patients without signiﬁcant coronary lesion who had spastic
coronary angiogram at baseline before Ach test deﬁned as % narrowing difference
>30% following intracoronary nitroglycerine injection were enrolled between
November 2004 and October 2010. Patients were divided into two groups according
to the response to the acetylcholine test (Ach responder group: n¼495, Ach non-S50 JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstractsresponder group: n¼233) and clinical outcomes were compared between the two
groups up to 3 years.
Results: Baseline characteristics were matched using propensity score matching.
Ischemic ECG change during Ach test was more frequent in Ach responder group
(p<0.001). There was no signiﬁcant difference in mortality or major adverse
cardiac & cerebrovascular events (MACE) between the two groups. However, the
Ach responder group showed signiﬁcant higher rate of recurrent chest pain which
subsequently needed re-evaluation of coronary artery (OR; 3.05, 95%CI; 1.32-
7.01, p¼0.009). And this difference remained signiﬁcant after multivariate anal-
ysis of other cardiovascular risk factors (OR; 3.22, 95%CI; 1.43-7.27, p¼0.005,
Fig 1).
Conclusion: Ach responsive patients who had increase coronary spastic tone was
associated with recurrent chest pain and higher rate of follow up coronary angiog-
raphy. Therefore, more intensive anti-spastic medication and close clinical follow up
would be needed for these patients.TCTAP A-177
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Background: Metabolic Syndrome (MS) has been known to be an important car-
diovascular risk factor. We investigated whether the presence of MS can impact on
coronary artery spasm (CAS) as assessed with intracoronary acetylcholine (Ach)
provocation test.
Methods: A total 3490 consecutive patients (pts) who underwent coronary angiog-
raphy with Ach provocation test were enrolled. National Cholesterol Education Pro-
gram Adult Treatment Panel III (NCEP-ATP III) was used for the deﬁnition of the
MS. The pts were divided into two groups; MS group (n¼680,19.5%) and non-MS
group (n¼2810, 80.5%) groups. Ach provocation test was performed by incremental
dosage (20, 50, 100ug) into left coronary artery. Signiﬁcant CAS was deﬁned more
than >70% luminal narrowing visually with chest pain with/without ST segment
changes.
Results: Baseline characteristics were balanced between the two groups except the
MS group had more elderly, hypertension, diabetes, dyslipidemia, and cerebro-
vascular accident, whereas the male gender, peripheral vascular disease, current
smoking and alcohol were lower in the MS group. Angiography characteristics
during Ach provocation test, the MS group showed higher incidence of QCA
measured severe CAS, mean % narrowing and smaller mean diameter than non-MS
group (Table).
Conclusion: According to our study, the MS pts had more coronary risk factors and
worse angiographic characteristics during Ach provocation test, suggesting more
careful medical therapy and follow up would be required./POSTER/High Risk Patients: Diabetes, Heart Failure, Renal Failure, Others
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Background: Coronary artery spasm (CAS) is a major cause of myocardial ischemia.
However, the incidence and clinical prognosis of diffuse CAS compared with focal
CAS has not been fully investigated. We compared diffuse CAS with focal CAS in
patients (pts) with vasospastic angina based on 3-year clinical outcomes.
Methods: A total of 2,797 consecutive pts without signiﬁcant coronary artery disease
(CAD) who underwent Acetylcholine (Ach) provocation test were enrolled between
Nov. 2004 and Oct. 2010. Patients were divided into three groups according to Ach
test results and spasm extent (CAS negative; n¼1,188, Diffuse CAS,  20mm;
n¼1,344, Focal CAS, < 20mm; n¼265).
Results: Baseline characteristics were similar between diffuse and focal groups.
Angiographically, the diffuse group showed higher incidence of multi-vessel spasm
(39.2% vs. 10.1%, p<0.01) and ECG changes (6.7 vs. 3.3%. p¼0.03), whereas the
focal group had more myocardial bridges (24.3 vs. 40.8%, p<0.01). Three-year
clinical outcomes including mortality, cardio & cerebro-vascular disease and recurrent
chest pain were similar between the two groups. When respectively compared with
CAS negative group, only diffuse CAS was shown to be an independent predictor of
recurrent chest pain (6.7% vs. 3.7%, p<0.01), even after adjustment using propensity
score matching (OR; 1.63, 95% C.I; 1.08-2.46).
Conclusion: In this study, diffuse CAS was associated with adverse 3-year clinical
outcomes. Therefore, intensive anti-anginal management and close clinical follow up
would be needed for pts who showed diffuse CAS during Ach provocation test.
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Background: Chronic total occlusion (CTO) intervention is still challenging because
of the limited procedural success rate and high target failure. The impact of percu-
taneous coronary intervention (PCI) for CTO in the left anterior descending artery
(LAD) is not clear. We evaluated the 12-month clinical outcomes between PCI and
optimal medical therapy (OMT) for LAD-CTO patients.
Methods: A total of 218 consecutive CTO patients were divided into 2 groups ac-
cording to treatment strategy; PCI group (n¼117) and OMT group (n¼101). 12-month
clinical outcomes were compared between the two groups.
Results: At baseline, the OMT group had a higher prevalence of elderly, congestive
heart failure, left main disease, multivessel disease, multivessel CTO, LCX-CTO,
RCA-CTO, and well-developed collaterals (grade 2), whereas the PCI group had a
higher prevalence of current smokers. Clinical outcomes at 12 months after baseline
adjustment by multivariate analysis showed similar major hard endpoints including
mortality, myocardial infarction, revascularization and major adverse cardiac events
(Table).
Conclusion: In our study, PCI seems to have no beneﬁt over OMT in left anterior
descending artery chronic total occlusion. Long-term follow up with a larger study
population will be necessary for further evaluation.
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Background: It has been reported that signiﬁcant endothelial dysfunction or clinically
evident vasospasm can be associated with drug-eluting stents (DESs). However, the
impact of DES associated coronary artery spasm (CAS) on 3-year clinical outcomes in
patients (pts) with vasospastic angina has not been fully elucidated.
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